Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: P53 protects lung cancer cells against metabolic stress
Authors: Chompunoot Sinthupibulyait
Wanida Ittarat
Clair, William H. St.
Clair, Daret K. St.
Keywords: 2-deoxy-D-glucose;p53;cancer metabolism;oxidative stress;Open Access article
Issue Date: 2010
Citation: International Journal of Oncology. Vol.37, No.6 (2010), 1575-1581
Abstract: Abstract. The preferential use of aerobic glycolysis for energy production by cancer cells, a phenomenon known as the ‘Warburg effect’, is well recognized and is being considered for therapeutic applications. However, whether inhibition of glycolysis will be effective in all types of cancer is unclear. The current study shows that a glycolytic inhibitor, 2-deoxy- D-glucose (2DG), exhibits the cytotoxic effect on non-small cell lung cancer in a p53-dependent manner. 2DG significantly inhibits ATP production in p53-deficient lung cancer cells (H358) but not in p53-wt cells (A549). In contrast to p53-wt cells, p53-defective cells are unable to compensate for their need of energy via oxidative phosphorylation (OXPHOS) when glycolysis is inhibited. In the presence of p53, increased ROS from OXPHOS increases the expression of p53 target genes known to modulate metabolism, including synthesis of cytochrome c oxidase 2 (SCO2) and TP53-induced glycolysis and apoptosis regulator (TIGAR). Importantly, 2DG selectively induces the expression of the antioxidant enzymes manganese superoxide dismutase (MnSOD) and glutathione peroxidase 1 (GPx1) in a p53-dependent manner. The results demonstrate that the killing of cancer cells by the inhibitor of glycolysis is more efficient in cancer cells without functional p53 and that p53 protects against metabolic stress by up-regulation of oxidative phosphorylation and modulation of antioxidants.
Appears in Collections:MT-Article

Files in This Item:
File Description SizeFormat 
mt-ar-wanida-2011.pdf1.19 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.